| Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient-and rater-blinded, randomized, controlled study JF Greden, SV Parikh, AJ Rothschild, ME Thase, BW Dunlop, ... Journal of psychiatric research 111, 59-67, 2019 | 246 | 2019 |
| Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous … S Preskorn, M Macaluso, M DO VISHAAL, G Zammit, JR Moskal, ... Journal of Psychiatric Practice® 21 (2), 140-149, 2015 | 200 | 2015 |
| Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2× 2 double-blind, randomized, placebo-controlled, phase IIA clinical trial JB Savitz, TK Teague, M Misaki, M Macaluso, BE Wurfel, M Meyer, ... Translational psychiatry 8 (1), 27, 2018 | 122 | 2018 |
| Introduction of the DSM-5 levels of Personality Functioning Questionnaire. SK Huprich, SM Nelson, KB Meehan, CJ Siefert, G Haggerty, J Sexton, ... Personality Disorders: Theory, Research, and Treatment 9 (6), 553, 2018 | 117 | 2018 |
| Other antidepressants TE Schwasinger-Schmidt, M Macaluso Antidepressants: From Biogenic Amines to New Mechanisms of Action, 325-355, 2019 | 65 | 2019 |
| Impact of pharmacogenomics on clinical outcomes for patients taking medications with gene-drug interactions in a randomized controlled trial ME Thase, SV Parikh, AJ Rothschild, BW Dunlop, C DeBattista, ... The Journal of clinical psychiatry 80 (6), 22039, 2019 | 56 | 2019 |
| Wernicke's encephalopathy: increasing clinician awareness of this serious, enigmatic, yet treatable disease A Flynn, M Macaluso, D Inna, MM Troutman The primary care companion for CNS disorders 17 (3), 27008, 2015 | 51 | 2015 |
| How biomarkers will change psychiatry: from clinical trials to practice. Part I: introduction M Macaluso, SH Preskorn Journal of Psychiatric Practice® 18 (2), 118-121, 2012 | 32 | 2012 |
| Combinatorial pharmacogenomic algorithm is predictive of citalopram and escitalopram metabolism in patients with major depressive disorder RC Shelton, SV Parikh, RA Law, AJ Rothschild, ME Thase, BW Dunlop, ... Psychiatry Research 290, 113017, 2020 | 25 | 2020 |
| Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial BW Dunlop, SV Parikh, AJ Rothschild, ME Thase, C DeBattista, ... BMC psychiatry 19, 1-10, 2019 | 25 | 2019 |
| Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study A Breier, RW Buchanan, D D'Souza, K Nuechterlein, S Marder, W Dunn, ... Schizophrenia research 206, 291-299, 2019 | 25 | 2019 |
| Duloxetine for the treatment of generalized anxiety disorder: a review AY Khan, M Macaluso Neuropsychiatric Disease and Treatment, 23-31, 2009 | 25 | 2009 |
| How commonly used inclusion and exclusion criteria in antidepressant registration trials affect study enrollment SH Preskorn, M Macaluso, M Trivedi Journal of Psychiatric Practice® 21 (4), 267-274, 2015 | 22 | 2015 |
| The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review AY Khan, M Macaluso, RJ Mchale, MM Dahmen, K Girrens, F Ali Journal of Psychiatric Practice® 16 (5), 289-296, 2010 | 22 | 2010 |
| Tardive dyskinesia: a historical perspective M Macaluso, A Flynn, SH Preskorn Journal of Psychiatric Practice® 23 (2), 121-129, 2017 | 21 | 2017 |
| Twenty percent of a representative sample of patients taking bupropion have abnormal, asymptomatic electroencephalographic findings M Macaluso, R Zackula, I D'Empaire, B Baker, K Liow, SH Preskorn Journal of clinical psychopharmacology 30 (3), 312-317, 2010 | 21 | 2010 |
| Convergent and discriminant validity and utility of the DSM–5 Levels of Personality Functioning Questionnaire (DLOPFQ): Associations with medical health care provider ratings … SM Nelson, SK Huprich, KB Meehan, C Siefert, G Haggerty, J Sexton, ... Journal of Personality Assessment 100 (6), 671-679, 2018 | 20 | 2018 |
| Vortioxetine versus placebo for major depressive disorder: a comprehensive analysis of the clinical trial dataset N Iovieno, GI Papakostas, A Feeney, M Fava, SJ Mathew, DI Iosifescu, ... The Journal of Clinical Psychiatry 82 (4), 34253, 2021 | 19 | 2021 |
| Combinatorial pharmacogenomic testing improves outcomes for older adults with depression BP Forester, SV Parikh, S Weisenbach, O Ajilore, I Vahia, AJ Rothschild, ... The American Journal of Geriatric Psychiatry 28 (9), 933-945, 2020 | 19 | 2020 |
| Knowledge of the pharmacology of antidepressants and antipsychotics yields results comparable with pharmacogenetic testing M Macaluso, SH Preskorn Journal of Psychiatric Practice® 24 (6), 416-419, 2018 | 18 | 2018 |
